Jennison Associates
TDOC icon

Jennison Associates’s Teladoc Health TDOC Stock Holding History

Jennison Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Sell
157,287
-1,545
-1% -$10.3K ﹤0.01% 483
2026
Q1 		$866K Buy
158,832
+58,472
+58% +$328K ﹤0.01% 507
2025
Q4 		$703K Buy
100,360
+16,058
+19% +$126K ﹤0.01% 539
2025
Q3 		$652K Sell
84,302
-68
-0.1% -$531 ﹤0.01% 515
2025
Q2 		$735K Sell
84,370
-7,330
-8% -$53.1K ﹤0.01% 518
2025
Q1 		$730K Sell
91,700
-35,318
-28% -$357K ﹤0.01% 511
2024
Q4 		$1.15M Sell
127,018
-41,148
-24% -$397K ﹤0.01% 477
2024
Q3 		$1.54M Buy
+168,166
New +$1.39M ﹤0.01% 451
2021
Q4 		– Sell
-1,008,967
Closed -$128M – 725
2021
Q3 		$128M Buy
1,008,967
+64,946
+7% +$9.46M 0.08% 100
2021
Q2 		$157M Sell
944,021
-458,152
-33% -$74.2M 0.1% 88
2021
Q1 		$255M Sell
1,402,173
-4,163,984
-75% -$966M 0.19% 63
2020
Q4 		$1.11B Sell
5,566,157
-391,386
-7% -$79.6M 0.79% 35
2020
Q3 		$1.31B Buy
5,957,543
+2,283,596
+62% +$484M 1.05% 24
2020
Q2 		$701M Buy
3,673,947
+3,217,743
+705% +$564M 0.63% 45
2020
Q1 		$70.7M Sell
456,204
-421,294
-48% -$49M 0.09% 100
2019
Q4 		$73.5M Sell
877,498
-234,391
-21% -$17.8M 0.07% 147
2019
Q3 		$75.3M Sell
1,111,889
-60,246
-5% -$3.97M 0.08% 144
2019
Q2 		$77.8M Buy
1,172,135
+442,140
+61% +$25.8M 0.08% 146
2019
Q1 		$40.6M Sell
729,995
-11,594
-2% -$708K 0.04% 259
2018
Q4 		$36.8M Sell
741,589
-432,702
-37% -$26.5M 0.04% 254
2018
Q3 		$101M Sell
1,174,291
-2,900
-0.2% -$207K 0.09% 137
2018
Q2 		$68.3M Sell
1,177,191
-440,317
-27% -$21.5M 0.07% 210
2018
Q1 		$65.2M Sell
1,617,508
-178,880
-10% -$6.75M 0.06% 219
2017
Q4 		$62.6M Buy
1,796,388
+3,050
+0.2% +$101K 0.06% 233
2017
Q3 		$59.4M Buy
1,793,338
+1,013,707
+130% +$33.2M 0.06% 247
2017
Q2 		$27.1M Buy
+779,631
New +$22.7M 0.03% 358
2015
Q4 		– Sell
-1,423,322
Closed -$31.7M – 733
2015
Q3 		$31.7M Buy
+1,423,322
New +$38.4M 0.03% 373

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Jennison Associates's TDOC Position: Q2 2026 in Review

Jennison Associates reduced its Teladoc Health (TDOC) stake by 0.97% in Q2 2026, selling an estimated $10.3K and leaving 157,287 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #483.

Jennison Associates first reported a position in TDOC in Q3 2015 and has held it in 27 quarters since. The position peaked at $1.31B in Q3 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Jennison Associates held 157,287 shares of Teladoc Health worth $1.33M as of Q2 2026.
  • Jennison Associates sold 1,545 Teladoc Health shares in Q2 2026, an estimated $10.3K.
  • Teladoc Health made up ﹤0.01% of Jennison Associates's portfolio in Q2 2026, its #483 holding.
  • Jennison Associates first reported a position in Teladoc Health in Q3 2015 and has held it in 27 quarters since.
  • Jennison Associates's Teladoc Health position peaked at $1.31B in Q3 2020.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.